Skip to content
1887

Journal of Medical Microbiology logo Journal of Medical Microbiology

Volume 71, Issue 7

Simultaneously screening for methicillin-resistant and its susceptibility to potentiated penicillins Open Access

Abstract

We recently revealed that a significant proportion of clinical methicillin-resistant (MRSA) isolates are susceptible to pencillins and clavulanic acid (potentiated penicillins), including widely available combinations such as co-amoxiclav. These isolates also showed increased susceptibility to oxacillin on Iso-Sensitest Agar (ISA).

The increased susceptibility to oxacillin displayed on ISA by these MRSA isolates may be used to distinguish them from the resistant ones.

We aimed to develop a method to simultaneously screen a clinical isolate for its susceptibility to methicillin and potentiated penicillins.

A double-disc diffusion method using 10 µg cefoxitin and 1 µg oxacillin discs on ISA was developed and tested against a panel of 120 whole genome-sequenced MRSA isolates. The sensitivity of the method was compared with that of previously published genotypic and phenotypic methods. In addition, double-disc diffusion was performed for all isolates on Müller–Hinton agar (MHA) following the European Committee on Antimicrobial Susceptibility Testing (EUCAST) protocol.

All isolates (120/120) were reconfirmed to be phenotypically MRSA, as indicated by the result of cefoxitin disc diffusion testing. All isolates (40/40) that had a pencillins and clavulanic acid (Pen–Clav)-resistant genotype were not inhibited by oxacillin, while 77/80 (96.3 %) isolates that had a Pen–Clav-susceptible genotype were inhibited by oxacillin on ISA. The results also showed that the EUCAST method using MHA correctly identified all isolates as MRSA but failed to distinguish the Pen–Clav-susceptible isolates from the Pen–Clav-resistant isolates.

This double-disc diffusion method using ISA could be used to accurately screen for clinical MRSA isolates and determine their susceptibility to Pen–Clav simultaneously, rapidly identifying MRSA infections that might be suitable for treatment with potentiated penicillins.

  • Received:
  • Accepted:
  • Published Online:
Keyword(s): antimicrobial resistance , iso-sensitest agar , MRSA and potentiated penicillins
© 2022 The Authors
  • This is an open-access article distributed under the terms of the Creative Commons Attribution License. This article was made open access via a Publish and Read agreement between the Microbiology Society and the corresponding author’s institution.
Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.001562
2022-07-22
2025-03-23
Loading full text...

Full text loading...

/deliver/fulltext/jmm/71/7/jmm001562.html?itemId=/content/journal/jmm/10.1099/jmm.0.001562&mimeType=html&fmt=ahah

References

  1. Chambers HF, Deleo FR. Waves of resistance: Staphylococcus aureus in the antibiotic era. Nat Rev Microbiol 2009; 7:629–641 [View Article] [PubMed]
     [Google Scholar]
  2. Foster TJ. Antibiotic resistance in Staphylococcus aureus. Current status and future prospects. FEMS Microbiol Rev 2017; 41:430–449 [View Article] [PubMed]
     [Google Scholar]
  3. Harrison EM, Ba X, Coll F, Blane B, Restif O et al. Genomic identification of cryptic susceptibility to penicillins and β-lactamase inhibitors in methicillin-resistant Staphylococcus aureus. Nat Microbiol 2019; 4:1680–1691 [View Article] [PubMed]
     [Google Scholar]
  4. Chen Y, Sun L, Ba X, Jiang S, Zhuang H et al. Epidemiology, evolution and cryptic susceptibility of methicillin-resistant Staphylococcus aureus in China: a whole-genome-based survey. Clin Microbiol Infect 2022; 28:85–92 [View Article] [PubMed]
     [Google Scholar]
  5. Quainoo S, Coolen JPM, van Hijum SAFT, Huynen MA, Melchers WJG et al. Whole-genome sequencing of bacterial pathogens: the future of nosocomial outbreak analysis. Clin Microbiol Rev 2017; 30:1015–1063 [View Article] [PubMed]
     [Google Scholar]
  6. The British Society for Antimicrobial Chemotherapy BSAC Methods for Antimicrobial Susceptibility Testing Version 14 British Society for Antimicrobial Chemotherapy; 2015
     [Google Scholar]
  7. Patel JB, Sharp S, Novak-Weekley S. Verification of antimicrobial susceptibility testing methods: a practical approach. Clin Microbiol Newsl 2013; 35:103–109 [View Article]
     [Google Scholar]
  8. Skov R, Smyth R, Clausen M, Larsen AR, Frimodt-Møller N et al. Evaluation of a cefoxitin 30 microg disc on Iso-Sensitest agar for detection of methicillin-resistant Staphylococcus aureus. J Antimicrob Chemother 2003; 52:204–207 [View Article] [PubMed]
     [Google Scholar]
  9. McDougal LK, Thornsberry C. The role of beta-lactamase in staphylococcal resistance to penicillinase-resistant penicillins and cephalosporins. J Clin Microbiol 1986; 23:832–839 [View Article] [PubMed]
     [Google Scholar]
  10. Milne LM, Crow MR, Emptage AG, Selkon JB. Effects of culture media on detection of methicillin resistance in Staphylococcus aureus and coagulase negative staphylococci by disc diffusion methods. J Clin Pathol 1993; 46:394–397 [View Article] [PubMed]
     [Google Scholar]
  11. Milne LM, Curtis GD, Crow M, Kraak WA, Selkon JB. Comparison of culture media for detecting methicillin resistance in Staphylococcus aureus and coagulase negative staphylococci. J Clin Pathol 1987; 40:1178–1181 [View Article] [PubMed]
     [Google Scholar]
  12. Broekema NM, Van TT, Monson TA, Marshall SA, Warshauer DM. Comparison of cefoxitin and oxacillin disk diffusion methods for detection of mecA-mediated resistance in Staphylococcus aureus in a large-scale study. J Clin Microbiol 2009; 47:217–219 [View Article] [PubMed]
     [Google Scholar]
  13. Fernandes CJ, Fernandes LA, Collignon P. Australian Group on Antimicrobial Resistance Cefoxitin resistance as a surrogate marker for the detection of methicillin-resistant Staphylococcus aureus. J Antimicrob Chemother 2005; 55:506–510 [View Article] [PubMed]
     [Google Scholar]
  14. Prestinaci F, Pezzotti P, Pantosti A. Antimicrobial resistance: a global multifaceted phenomenon. Pathog Glob Health 2015; 109:309–318 [View Article] [PubMed]
     [Google Scholar]
  15. Davis JS, Van Hal S, Tong SYC. Combination antibiotic treatment of serious methicillin-resistant Staphylococcus aureus infections. Semin Respir Crit Care Med 2015; 36:3–16 [View Article] [PubMed]
     [Google Scholar]
  16. Holland TL, Davis JS. Combination therapy for MRSA bacteremia: To ß or Not to ß?. Clin Infect Dis 2020; 71:11–13 [View Article] [PubMed]
     [Google Scholar]
  17. Kelesidis T, Humphries R, Ward K, Lewinski MA, Yang OO. Combination therapy with daptomycin, linezolid, and rifampin as treatment option for MRSA meningitis and bacteremia. Diagn Microbiol Infect Dis 2011; 71:286–290 [View Article] [PubMed]
     [Google Scholar]
  18. Ba X, Harrison EM, Lovering AL, Gleadall N, Zadoks R et al. Old drugs to treat resistant bugs: methicillin-resistant Staphylococcus aureus isolates with mecC are susceptible to a combination of penicillin and clavulanic acid. Antimicrob Agents Chemother 2015; 59:7396–7404 [View Article] [PubMed]
     [Google Scholar]
/content/journal/jmm/10.1099/jmm.0.001562
Loading
Simultaneously screening for methicillin-resistant Staphylococcus aureus and its susceptibility to potentiated penicillins
J. Med. Microbiol. 71, 001562 (2022); https://doi.org/10.1099/jmm.0.001562
/content/journal/jmm/10.1099/jmm.0.001562
/content/journal/jmm/10.1099/jmm.0.001562
Loading

Data & Media loading...

Supplements

Supplementary material 1

EXCEL

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error